EACR 2023 Congress: Innovative Cancer Science

Event Serial: WCA513554

Views: 78

12th Jun 2023 To 15th Jun 2023

EACR 2023 Congress: Innovative Cancer Science


Contact Person - New Way Management

Event inquiry /Organizer email address - eacr@newway-management.com

Organized by: The European Association for Cancer Research

Topic Covered: Cancer, Bioinformatics, Biotechnology, Oncology, Cancer

  • Event Start Date - 12th Jun 2023
  • Deadline for abstracts/proposals: 06th Mar 2023
  • Event End Date - 15th Jun 2023

Venue: Turin , Italy

About Event:

The 2023 Annual Congress of the European Association for Cancer Research EACR 2023 is a four-day congress dedicated to basic, preclinical, and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections, and collaborations. The delegate population will thus simulate the multidisciplinary teams that act in the real world to facilitate interdisciplinary research and patient treatment and care. The Congress will include various symposia and educational lectures, meet-the-expert workshops, keynote lectures from a range of renowned names in cancer research, and career discovery sessions dedicated to young researchers new to the field. Deadlines: Travel grant application deadline: 06 March 2023 Abstract submission deadline: 06 March 2023 Early registration deadline: 24 April 2023 Speakers: Nicola Aceto Switzerland, Julio Aguirre-Ghiso USA, Raza Ali UK, Chiara Ambrogio Italy, Allan Balmain USA, Mariano Barbacid Spain, Roderick Beijersbergen Netherlands, Carlos Caldas UK, Peter Campbell UK, Arkaitz Carracedo Spain, Chiara Maria Cattaneo Italy, Roberto Chiarle Italy, Francesca Ciccarelli UK, Direna Alonso Curbelo Spain, Mark Dawson USA, Johann de Bono UK, Martin Eilers Germany, John Haanen Netherlands, Simon Haas Germany, Doug Hannahan Switzerland, Johanna A. Joyce Switzerland, Christoph Klein Germany, Marleen Kok Netherlands, Evi Lianidou Greece, Nuria Lopez-Bigas Spain, Shiva Malek Switzerland, Elaine R. Mardis USA, Silvia Marsoni Italy, Ingio Martincorena UK, Joaquin Mateo Spain, Cristina Mayor-Ruiz Spain, Massimiliano Mazzone Belgium, Rene Medema Netherlands, Sandra Misale USA, Luigi Naldini Italy, Anna Obenauf Austria, Johanna Olweus Norway, Yaara Oren USA, Massimiliano Pagani Italy, Ruth Palmer Sweden, Ronald Plasterk Netherlands, Steve Pollard UK, Nikolaus Rajewsky Germany, Raphael Rodriguez France, Mariangela Russo Italy, Yardena Samuels Israel, Nicola Segata Italy, Marisol Soengas Spain, Ravid Straussman Israel, Mario Suva USA, Nicola Ternette USA, Andrea Viale USA, Rinse Weersma Netherlands, Jukka Westermarck Finland, George E. Winter Austria, and Mariia Yuneva UK Keywords: advanced T-cell therapies, cell competition, challenging drug targets, chemical biology, computational biology and AI, drug resistance, drugging the RAS pathway, microbiome and immune system interface, liquid biopsies, mechanism-based clinical trials, model organisms, neoantigens and vaccines, biology of early cancer, spatial transcriptomics, tumor metabolism, epigenetic control, tumor dormancy, tumor persistence, tumor ecology at single-cell level, tumor evolution, oncology

Feature Events

For Custom Banner please send mail admin@worldconferencealerts.com. Along with banner image (width 1200px Height 300px) and event serial no.